Clinical trial to evaluate the efficacy and safety of [11C]K-2 in healthy volunteers
- Conditions
- healthy volunteer
- Registration Number
- JPRN-UMIN000020975
- Lead Sponsor
- Yokohama city university, school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 8
Not provided
1. The man cannot agree by himself 2. The man who has past or current history of psychiatric disorder 3. current smoker or past smoker who quit smoking within 6 months 4. The man who is disclosed brain disease by MRI study 5. The man who has pacemaker or metal object inside his body 6. The man who has tatoo 7. claustrophobia 8. The man who participates in clinical trial where he underwent nuclear medicine scan within 6 months 9. The man who donates his blood 400ml within 12 weeks or 200ml within 4 weeks or more little within 2 weeks 10. The man who participates in other clinical trial within 12 weeks 11. The man who continues and cannot quit using drugs 12. The man who is judged inadequate by the research medical doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To measure the dinamics and distribution volumes of [11C]K-2 in the brain.
- Secondary Outcome Measures
Name Time Method To study the adverse event about [11C]K-2 during post 4-10 days after administration of it.